Roche acquires THP in US$56.5m deal

Published: 2-Apr-2007
Media Ingredients Pharmaceutical

Global biotech company Roche has acquired privately held California-based biopharmaceutical company Therapeutic Human Polyclonals for US$56.5m.


Global biotech company Roche has acquired privately held California-based biopharmaceutical company Therapeutic Human Polyclonals for US$56.5m.

THP, which has a subsidiary in Germany, is focused on research in human antibody technologies. The company has developed a unique transgenic mammalian platform to create human antibodies. The technology will enable the generation of both monoclonal and polyclonal antibody therapeutics with enhanced efficacy.

The acquisition of THP strengthens Roche's expertise in therapeutic antibody research. Roche is a global leader in therapeutic antibodies with its cancer therapies MabThera, Herceptin and Avastin. Roche plans to fully integrate THP into the Roche Pharma Center of Excellence for Protein Research organisation in Penzberg, Germany.

'We are delighted that Roche will be taking THP's human antibody platform to the next stage,' said THP co-founder and ceo Wim Van Schooten. 'Roche is the ideal company for furthering development of this technology.'

See more

You may also like

Packaging

ProMach Pharma presents new equipment at Pack Expo Las Vegas

Read more
Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. ProMach Pharma presents new equipment at Pack Expo Las Vegas Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
  3. Bavarian Nordic launches chikungunya vaccine Vimkunya in the UK The UK announcement of the recombinant vaccine follows recent approval by the MHRA in May 2025
  4. FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
  5. CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals with expanded focus on innovation and sustainability Returning to Germany from 28-30 October, CPHI Frankfurt 2025 will unite the global pharmaceutical supply chain with more than 2000 exhibitors, six content theatres and new feature zones

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Packaging

ProMach Pharma presents new equipment at Pack Expo Las Vegas

Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
Pharmaceutical

CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals with expanded focus on innovation and sustainability

Returning to Germany from 28-30 October, CPHI Frankfurt 2025 will unite the global pharmaceutical supply chain with more than 2000 exhibitors, six content theatres and new feature zones
Manufacturing

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
Pharmaceutical

Keystone Folding Box Co. unveils Key-Pak Plus

Designed to protect children and empower seniors, it achieves top U.S. safety ratings and meets global accessibility standards
Pharmaceutical

Bavarian Nordic launches chikungunya vaccine Vimkunya in the UK

The UK announcement of the recombinant vaccine follows recent approval by the MHRA in May 2025
Research & Development

Servier and IDEAYA Biosciences join forces to bring a promising new eye cancer treatment to patients across the globe

Servier and IDEAYA Biosciences have entered into an exclusive license agreement for regulatory and commercial rights to darovasertib outside the US
Pharmaceutical

Atelerix and Rodon Global enter new partnership to create cryo-free logistics

The initial agreement will be to incorporate Atelerix’s non-cryogenic cell preservation technology into Rodon's international freight and logistics services for drug discovery and clinical trials
Subscribe now